These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17159818)

  • 1. Regional brain metabolism as the predictor of performance on the Trail Making Test in schizophrenia. A 18FDG PET covariation study.
    Horacek J; Dockery C; Kopecek M; Spaniel F; Novak T; Tislerova B; Klirova M; Palenicek T; Höschl C
    Neuro Endocrinol Lett; 2006 Oct; 27(5):587-94. PubMed ID: 17159818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An fMRI study of the Trail Making Test.
    Zakzanis KK; Mraz R; Graham SJ
    Neuropsychologia; 2005; 43(13):1878-86. PubMed ID: 16168730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trail Making Test in traumatic brain injury, schizophrenia, and normal ageing: sample comparisons and normative data.
    Periáñez JA; Ríos-Lago M; Rodríguez-Sánchez JM; Adrover-Roig D; Sánchez-Cubillo I; Crespo-Facorro B; Quemada JI; Barceló F
    Arch Clin Neuropsychol; 2007 May; 22(4):433-47. PubMed ID: 17336493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Trail Making Test: a study in focal lesion patients.
    Stuss DT; Bisschop SM; Alexander MP; Levine B; Katz D; Izukawa D
    Psychol Assess; 2001 Jun; 13(2):230-9. PubMed ID: 11433797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent effects of radiation therapy on cerebral blood flow, metabolism, and neurocognitive dysfunction.
    Hahn CA; Zhou SM; Raynor R; Tisch A; Light K; Shafman T; Wong T; Kirkpatrick J; Turkington T; Hollis D; Marks LB
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1082-7. PubMed ID: 18755558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An fMRI investigation of a novel analogue to the Trail-Making Test.
    Jacobson SC; Blanchard M; Connolly CC; Cannon M; Garavan H
    Brain Cogn; 2011 Oct; 77(1):60-70. PubMed ID: 21782309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing mental flexibility: neuroanatomical and neuropsychological correlates of the Trail Making Test in elderly people.
    Oosterman JM; Vogels RL; van Harten B; Gouw AA; Poggesi A; Scheltens P; Kessels RP; Scherder EJ
    Clin Neuropsychol; 2010 Feb; 24(2):203-19. PubMed ID: 20162494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
    Bar-Shalom R; Kagna O; Israel O; Guralnik L
    Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine H1 receptors in schizophrenic patients measured by positron emission tomography.
    Iwabuchi K; Ito C; Tashiro M; Kato M; Kano M; Itoh M; Iwata R; Matsuoka H; Sato M; Yanai K
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):185-91. PubMed ID: 15695063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm.
    Arbuthnott K; Frank J
    J Clin Exp Neuropsychol; 2000 Aug; 22(4):518-28. PubMed ID: 10923061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced glucose metabolism in temporo-parietal cortices of women with borderline personality disorder.
    Lange C; Kracht L; Herholz K; Sachsse U; Irle E
    Psychiatry Res; 2005 Jul; 139(2):115-26. PubMed ID: 15978784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the prefrontal cortex during the Trail-Making Test detected with multichannel near-infrared spectroscopy.
    Shibuya-Tayoshi S; Sumitani S; Kikuchi K; Tanaka T; Tayoshi S; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):616-21. PubMed ID: 18081621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trail making test errors and executive function in schizophrenia and depression.
    Mahurin RK; Velligan DI; Hazleton B; Mark Davis J; Eckert S; Miller AL
    Clin Neuropsychol; 2006 Jun; 20(2):271-88. PubMed ID: 16690547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal imaging in mild cognitive impairment: Metabolism, morphometry and diffusion of the temporal-parietal memory network.
    Walhovd KB; Fjell AM; Amlien I; Grambaite R; Stenset V; Bjørnerud A; Reinvang I; Gjerstad L; Cappelen T; Due-Tønnessen P; Fladby T
    Neuroimage; 2009 Mar; 45(1):215-23. PubMed ID: 19056499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone administration attenuates regional brain hypometabolism in women with anorexia nervosa.
    Miller KK; Deckersbach T; Rauch SL; Fischman AJ; Grieco KA; Herzog DB; Klibanski A
    Psychiatry Res; 2004 Dec; 132(3):197-207. PubMed ID: 15664791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined neuropsychological and brain imaging study of obstructive sleep apnea.
    Yaouhi K; Bertran F; Clochon P; Mézenge F; Denise P; Foret J; Eustache F; Desgranges B
    J Sleep Res; 2009 Mar; 18(1):36-48. PubMed ID: 19250174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy.
    Silverman DH; Dy CJ; Castellon SA; Lai J; Pio BS; Abraham L; Waddell K; Petersen L; Phelps ME; Ganz PA
    Breast Cancer Res Treat; 2007 Jul; 103(3):303-11. PubMed ID: 17009108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic characteristics and normative observations for derived-trail making test indices.
    Drane DL; Yuspeh RL; Huthwaite JS; Klingler LK
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Mar; 15(1):39-43. PubMed ID: 11877550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of PET and qEEG in normal subjects.
    Alper KR; John ER; Brodie J; Günther W; Daruwala R; Prichep LS
    Psychiatry Res; 2006 Apr; 146(3):271-82. PubMed ID: 16603341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.